-
Reasons for rejection of section 18A Authority for medicinal cannabis
Since April 2021 60 applications for s18A authority to prescribe medicinal cannabis have been
refused:
• The majority (55) of applications were refused because further information requested was
not provided.
Joint Committees
55th Parliament (Current)
-
Late last year we published the Cannabis in Australia 2022 Report, which
examined Australia's approach to medicinal cannabis, illicit cannabis and hemp in Australia.
Joint Committees
55th Parliament (Current)
-
Dear Secretary,
I am a long term Medical Cannabis user who has recently moved back to SA where I grew up
after many years in Tasmania where I ran the MCUAT patient support group.
Joint Committees
55th Parliament (Current)
-
“Cannabis & Employment”, https://nadk.flinders.edu.au/kb/cannabis/cannabis-employment/
20 Ibid.
Joint Committees
55th Parliament (Current)
-
Cannabis in South Australia -
What’s the Problem?
Joint Committees
55th Parliament (Current)
-
We did a literature review on cannabis and impairment.
Joint Committees
55th Parliament (Current)
-
SUBMISSION
Prepared by Michael Russell for the Joint Committee on the Legalisation of Medicinal
Cannabis.
Joint Committees
55th Parliament (Current)
-
Medicinal Cannabis has been proven to have amazing therapeutic benefits and this
realisation is creating immense demand for Cannabis that is high quality, consistent and has
a diversity of genetics.
Joint Committees
55th Parliament (Current)
-
The legislation does not discriminate between prescribed medicinal cannabis and illicit
cannabis.
Joint Committees
55th Parliament (Current)
-
Strict regulation is also
required in relation to the advertising and promotion of medicinal cannabis products to prevent
commercialisation of the cannabis industry.
Joint Committees
55th Parliament (Current)
